Skip to main content
TipRanks
Go Ultimate75% OFF

Welgene Biotech Co., Ltd. (6661) Balance Sheet

Welgene Biotech Co., Ltd. Balance Sheet

Welgene Biotech Co., Ltd.'s total assets for Q2 2026 were NT$658.59M, an increase of 10.68% from the previous quarter. TW:6661 total liabilities were NT$380.96M for the fiscal quarter, a 20.89% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 622.19MNT$ 528.25MNT$ 548.16MNT$ 435.71MNT$ 424.54M
NT$ 336.12MNT$ 232.50MNT$ 247.89MNT$ 131.76MNT$ 114.47M
NT$ 286.07MNT$ 295.75MNT$ 300.27MNT$ 303.95MNT$ 310.06M

Currency in TWD

Welgene Biotech Co., Ltd. Liabilities to Assets

0250M500M750M24 %36 %48 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets